Thyroid News

Living in an area with higher levels of outdoor artificial nighttime light appeared associated with higher risk for developing thyroid cancer, according to an observational study published in Cancer.

Although many cancer survivors go on to live healthy, cancer-free lives, the prospect of facing cancer again is an ongoing concern.

The FDA granted breakthrough therapy designation to cabozantinib for treatment of certain patients with thyroid cancer, according to the agent’s manufacturer.

Thyroid cancer incidence and mortality patterns among children and adolescents worldwide mirror data for adults, suggesting overdiagnosis and a need to “explicitly recommend” against screening for the disease in asymptomatic children.

Three large professional thyroid organizations issued a joint statement calling for new trials of combination therapy to treat hypothyroidism, citing new clinical endpoints and the importance of assessing patient-reported outcomes.

Most adults with free thyroxine levels slightly below the reference range have normal free T4 index values and did not have abnormal findings on pituitary imaging or functional tests, according to a study published in Endocrine Practice.

Central hypothyroidism is prevalent in about 1 in 2 adults with Cushing’s syndrome, and thyroid function can be restored after curative surgery for most patients, according to study findings.

A majority of adults with hypothyroidism responding to a survey said they were dissatisfied with treatment and reported having a low quality of life score, according to study data published in Clinical Endocrinology.

Low thyroid-stimulating hormone levels are positively associated with incident depression, particularly among women, and even among euthyroid adults, according to findings published in Clinical Endocrinology.

Long-term use of antithyroid drugs can be a viable alternative to ablative therapies for the management of Graves’ disease, according to a review article published in Clinical Endocrinology.